Consensus clinical practice guidelines of the Sociedad Andaluza de Epilepsia for the diagnosis and treatment of patients with their first epileptic seizure in emergencies;Guía de práctica clínica de consenso de la Sociedad Andaluza de Epilepsia para el diagnóstico y tratamiento del paciente con una primera crisis epiléptica en situaciones de urgencia

Revista de Neurologia

Volumn 48, Issue 1, 2009, Pages 39-50

  Serrano Castro, Pedro Jesús ^a   Sanchez Alvarez J C ^b   Canadillas Hidalgo F M ^c   Galan Barranco J M ^d   Moreno Alegre, V ^b   Mercade Cerda J M ^e  

^a HOSPITAL TORRECÁRDENAS   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Antiepileptic drugs; Clinical practice guidelines; Consensus; Diagnosis; Emergency department; Epilepsy; Evidence based medicine; First epileptic seizure; Health care protocol; Start of treatment; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG TOLERABILITY; ELECTROENCEPHALOGRAPHY; EMERGENCY CARE; EMERGENCY WARD; EVIDENCE BASED MEDICINE; HISTORY OF MEDICINE; HUMAN; INFORMATION PROCESSING; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL SOCIETY; PRACTICE GUIDELINE; SEIZURE;

EID: 61849151834     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4801.2008596     Document Type: Article

References (63)

1. Huff JS, Morris DL, Kothari RU, Gibbs MA, Emergency Medicine Seizure Study Group. Emergency department management of patients with seizures: a multicenter study. Acad Emerg Med 2001; 8: 622-8.
2. Tiamkao S, Sawanyawisuth K, Paowana W, Saengsuwan J, Arunpongpaisal S, Chaiyakum A, et al. Seizure presenting to the emergency department, Srinagarind Hospital. J Med Assoc Thai 2006; 89: 362-7.
3. Liberati A, Barro G. Clinical guidelines: social and cultural dimensions and juridical and medico-legal implications. Epidemiol Prev 1998; 22: 72-3.
4. Blume WT, Luders HO, Mizrahi E, Tassinari C, Van Emde-Boas W, Engel J Jr. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42: 1212-8.
5. Krumholz A. Nonepileptic seizures: diagnosis and management. Neurology 1999; 53 (Suppl 2): S76-83.
6. Bergfeldt L. Differential diagnosis of cardiogenic syncope and seizure disorders. Heart 2003; 89: 353-8.
7. Kaplan PW. Nonconvulsive status epilepticus in the emergency room. Epilepsia 1996; 37: 643-50.
8. Sánchez-Álvarez JC, Serrano-Castro PJ, Cañadillas- Hidalgo F. Epilepsia refractaria del adulto. Rev Neurol 2002; 35: 931-53.
9. Turnbull TL, Van den Hoek TL, Howes DS, Eisner RF. Utility of laboratory studies in the emergency department patient with a new-onset seizure. Ann Emerg Med 1990; 19: 373-7.
10. Powers RD. Serum chemistry abnormalities in adult patients with seizures. Ann Emerg Med 1985; 14: 416-20.
11. Sempere AP, Villaverde FJ, Martínez-Menéndez B, Cabeza C, Peña P, Tejerina JA. First seizure in adults: a prospective study from the emergency department. Acta Neurol Scand 1992; 86: 134-8.
12. Tardy B, Lafond P, Convers P, Page Y, Zeni F, Viallon A, et al. Adult first generalized seizure: etiology, biological tests, EEG, CT scan, in an ED. Am J Emerg Med 1995; 13: 1-5.
13. Medical management of first unprovoked seizure in children 2 to 18 years of age. Health Policy & Clinical Effectiveness Program. Cincinnati Children's Hospital Medical Center. 2002. URL: http://www.cincinnatichildrens. org/svc/alpha/h/health-policy/ev-based/seizure.htm [29.11.2008].
14. Hirtz D, Berg A, Bettis D, Camfield C, Camfield P, Crumrine P, et al. Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: treatment of the child with a first unprovoked seizure: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003; 60: 166-75.
15. Ramírez-Lassepas M, Cipolle RJ, Morillo LR, Gumnit RJ. Value of computed tomographic scan in the evaluation of adult patients after their first seizure. Ann Neurol 1984; 15: 536-43.
16. Serrano-Castro PJ, Olivares-Romero J, Guardado-Santervás, P. Caracterización epidemiológica de la epilepsia del adulto subsidiaria de ingreso hospitalario. Rev Neurol 2001; 32: 1013-9.
17. Hirtz D, Ashwal S, Berg A, Bettis D, Camfield C, Camfield P, et al. Practice parameter: evaluating a first nonfebrile seizure in children: report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society. Neurology 2000; 55: 616-23.
18. Scottish Intercollegiate Guidelines Network (SIGN). Guideline 70. Diagnosis and management of epilepsy in adults. Edinburgh; April 2003. URL: http://www.sign. ac.uk/pdf/sign70.pdf [29.11.2008].
19. ACEP Clinical Policies Committee; Clinical Policies Subcommittee on Seizures. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures. Ann Emerg Med 2004; 43: 605-25.
20. Recomendaciones para el uso de técnicas de imagen en el diagnóstico. Sistemas musculoesquelético y nervioso. Sevilla: Servicio Andaluz de Salud, Consejería de Salud de la Junta de Andalucía; 2004.
21. Pruebas diagnósticas en neurología. In: Indicaciones consensuadas con las sociedades científicas para los procedimientos diagnósticos más frecuentes, incluidos en el Decreto de Garantía de plazo de respuesta en el Sistema Sanitario Público de Andalucía. Sevilla: Servicio Andaluz de Salud, Consejería de Salud de la Junta de Andalucía; 2005.
22. Shinnar S, Kang H, Berg AT, Goldensohn ES, Hauser WA, Moshe SL. EEG abnormalities in children with a first unprovoked seizure. Epilepsia 1994; 35: 471-6.
23. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995; 12: 326-42.
24. Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR Jr, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000 25; 54: 340-5.
25. Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996; 47: 83-9.
26. Rider LG, Thapa PB, Del Beccaro MA, Gale JL, Foy HM, Farwell JR, et al. Cerebro-spinal fluid analysis in children with seizures. Pediatr Emerg Care 1995; 11: 226-9.
27. Annegers JF, Hauser WA, Lee JR, Rocca WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995; 36: 327-33.
28. Mauri-Llerda JA, Tejero-Juste C, Escalza-Cortina I, Jericó I, Morales-Asín F. Epilepsias agudas sintomáticas. Rev Neurol 2000; 31: 770-4.
29. Sander JW, Hart YM, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990; 336: 1267-71.
30. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.
31. Serrano-Castro PJ, Casado-Chocán JL, Mercadé-Cerdá JM, Altuzarra-Corral A, Rufo-Campos M, Moreno-Alegre V, et al. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005. Parte III: tratamiento antiepiléptico en situaciones especiales. Rev Neurol 2005; 40: 683-95.
32. Chang BS, Lowenstein DH, Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003; 60: 10-6.
33. Bialer M. Clinical pharmacology of parenteral use of antiepileptic drugs. Epilepsia 2007; 48 (Suppl 8): S46-8.
34. Abasolo-Osinaga E, Abecia-Inchaurregui LC, Etxeandia-Ikobaltzeta I, Burgos-Alonso N, García-del Pozo J. Estudio farmacoepidemiológico del consumo de fármacos antiepilépticos (1992-2004). Rev Neurol 2008; 46: 449-53.
35. Fernández RJ, Samuels MA. Epilepsy. In Samuels MA, ed. Manual of neurological therapeutics. 5 ed. Boston: Little-Brown; 1995. p. 89-127.
36. Wilder BJ. Phenytoin. In Shorvon S, Dreifuss F, Fish D, Thomas D, eds. The treatment of epilepsy. Oxford: Blackwell Science; 1996. p. 454-65.
37. Cañadillas F, Montero FJ, Jiménez L, Molina T. Crisis epilépticas. In Jiménez L, Montero FJ, eds. Medicina de urgencias y emergencias. Guía diagnóstica y protocolos de actuación. 3 ed. Madrid: Elsevier; 2004. p. 359-66.
38. Wilder BJ, Serrano EE, Ramsay RE. Plasma diphenylhydantoin levels after loading and maintenance doses. Clin Pharmacol Ther 1973; 14: 797-801.
39. Van der Meydem CH, Kruger AJ, Müller FO, Rabie W, Schall R. Acute oral loading of carbamazepine-CR and phenitoin in a double-blind randomized study of patients at risk of seizures. Epilepsia 1994; 35: 189-94.
40. Mattson RH. Parenteral antiepileptic/anticonvulsant drugs. Neurology 1996; 46 (Suppl 1): S8-13.
41. Louis S, Kutt H, McDowell F. The cardiocirculatory changes caused by intravenous dilantin and its solvent. Am Heart J 1967; 174: 523-9.
42. Serrano-Castro PJ, Ramos-Lizana J, Pita-Calandre E, Camino-León R, Galán-Barranco JM, Rufo-Campos M, et al. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005. Parte I: criterios de inicio y cese de tratamiento, bases farmacológicas y principios del tratamiento con fármacos a largo plazo. Rev Neurol 2005; 40: 563-71.
43. García-Morales I, Sancho-Rieger J, Gil-Nagel A, Herranz-Fernández JL. Antiepileptic drugs: from scientific evidence to clinical practice. Neurologist 2007; 13 (Suppl 1): S20-8.
44. Limdi NA, Knowlton RK, Cofield SS, Ver Hoef LW, Paige AL, Dutta S, et al. Safety of rapid intravenous loading of valproate. Epilepsia 2007; 48: 478-83.
45. Venkataraman V, Wheless JW. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 1999; 35: 147-53.
46. Wheless JW, Vázquez BR, Kanner AM, Ramsay RE, Morton L, Pellock JM. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004; 63: 1507-8.
47. Bogas JG, Preis K. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit. Epilepsia 2005; 46: 949-51.
48. Olsen KB, Tauboll E, Gjerstad L. Valproate is a effective, well-tolerated drug for treatment of status epilepticus/serial attacks in adults. Acta Neurol Scand Suppl 2007; 187: 51-4.
49. Yu K, Mills S, Thompson N, Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 2003; 44: 724-6.
50. Gerstner T, Bell N, Longin E, König S. Oral rapid loading of valproic acid -an alternative to the usual saturation scheme? Seizure 2006; 15: 630-2.
51. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000; 55: 722-4.
52. Gutiérrez-Gutiérrez G, Poza-Aldea JJ, Tellería- Elmezábal J, Martí-Massó JF. Estudio retrospectivo comparando dos formulaciones de ácido valproico. Rev Neurol 2006; 42: 129-32.
53. Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 2006; 47: 1128-35.
54. Baulac M, Voss G, Krygier C, Flatter U. Safety profile of levetiracetam infusion (1.000-3.000 mg/day) in bid administration in patients with partial-onset seizure. Epilepsia 2005; 46: 169.
55. Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 2004; 43: 707-24.
56. French J, Arrigo C. Rapid onset of action of levetiracetam in refractory epilepsy patients. Epilepsia 2005; 46: 324-6.
57. Baulac M, Brodie J, Elger C, Krakow K, Stokis A, Meyvisch P, et al. Levetiracetam intravenous infusion as an alternative to oral doping in patients with partial-onset seizures. Epilepsia 2007; 48: 589-92.
58. Panayiotopoulos CP. Antiepileptic drug therapy with emphasis on focal epilepsies. In Panayiotopoulos CP, ed. A clinical guide to antiepileptic syndromes and their treatment. 2 ed. New York: Springer; 2007. p. 1-24.
59. Molins A, Villanueva VE. Levetiracetam en el tratamiento de la epilepsia del adulto. Experiencia en monoterapia. Rev Neurol 2007; 45: 331-3.
60. Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, et al. Use of levetiracetam in hospitalized patients. Epilepsia 2006; 47: 2186-8.
61. Rüegg S, Naegelin Y, Hardmeier M, Winkler DT, Marsch S, Fuhr P. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 2008; 12: 477-80.
62. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991; 41: 965-72.
63. Hauser WA, Rich SS, Lee JR, Annegers JF, Anderson VE. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998; 338: 429-34.